These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36401652)

  • 1. Effect of low-dose atropine eyedrops on pupil metrics: results after half a year of treatment and cessation.
    Bai WL; Gan JH; Wei S; Li SM; An WZ; Liang XT; Tian JX; Yin L; Wang N
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1177-1186. PubMed ID: 36401652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
    Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
    Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
    Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
    Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
    JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopia progression after cessation of low-dose atropine eyedrops treatment: A two-year randomized, double-masked, placebo-controlled, cross-over trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Gan J; Bai W; Tian J; Cai Z; Yin L; Wang N
    Acta Ophthalmol; 2023 Mar; 101(2):e177-e184. PubMed ID: 35999653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
    Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
    Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
    Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
    Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
    Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P
    Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.
    Tan Q; Ng AL; Choy BN; Cheng GP; Woo VC; Cho P
    Ophthalmic Physiol Opt; 2020 Sep; 40(5):557-566. PubMed ID: 32776533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
    Chia A; Lu QS; Tan D
    Ophthalmology; 2016 Feb; 123(2):391-399. PubMed ID: 26271839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
    Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
    Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.
    Yam JC; Zhang XJ; Zhang Y; Yip BHK; Tang F; Wong ES; Bui CHT; Kam KW; Ng MPH; Ko ST; Yip WWK; Young AL; Tham CC; Chen LJ; Pang CP
    JAMA; 2023 Feb; 329(6):472-481. PubMed ID: 36786791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Low-dose Atropine on Binocular Vision and Accommodation in Children Aged 6 to 17 Years.
    Breliant RE; Pang Y; Bandstra A; Kattouf V
    Optom Vis Sci; 2023 Aug; 100(8):550-556. PubMed ID: 37278695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of atropine 1% in children with low myopia.
    Yi S; Huang Y; Yu SZ; Chen XJ; Yi H; Zeng XL
    J AAPOS; 2015 Oct; 19(5):426-9. PubMed ID: 26228967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of 1% Atropine on Retardation of Moderate Myopia Progression in Chinese School Children.
    Zhu Q; Tang Y; Guo L; Tighe S; Zhou Y; Zhang X; Zhang J; Zhu Y; Hu M
    Int J Med Sci; 2020; 17(2):176-181. PubMed ID: 32038101
    [No Abstract]   [Full Text] [Related]  

  • 17. Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study.
    Chia A; Ngo C; Choudry N; Yamakawa Y; Tan D
    Asia Pac J Ophthalmol (Phila); 2023 Jul-Aug 01; 12(4):370-376. PubMed ID: 37523428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.
    Hieda O; Hiraoka T; Fujikado T; Ishiko S; Hasebe S; Torii H; Takahashi H; Nakamura Y; Sotozono C; Oshika T; Morimoto T; Nishida K; Nishikawa N; Song YS; Tokutake T; Nishi Y; Shigeno Y; Kurihara T; Negishi K; Tsubota K; Ono M; Nakai T; Tan D; Tanaka S; Kinoshita S;
    Jpn J Ophthalmol; 2021 May; 65(3):315-325. PubMed ID: 33586090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol.
    Azuara-Blanco A; Logan N; Strang N; Saunders K; Allen PM; Weir R; Doherty P; Adams C; Gardner E; Hogg R; McFarland M; Preston J; Verghis R; Loughman JJ; Flitcroft I; Mackey DA; Lee SS; Hammond C; Congdon N; Clarke M
    Br J Ophthalmol; 2020 Jul; 104(7):950-955. PubMed ID: 31653669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of low-concentration atropine eye drops on pupil size and accommodation in young adult subjects.
    Kaymak H; Fricke A; Mauritz Y; Löwinger A; Klabe K; Breyer D; Lagenbucher A; Seitz B; Schaeffel F
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2211-2217. PubMed ID: 30145612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.